Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parallax Health Sciences is a healthcare technology company that specialized in remote patient monitoring, diagnostics, and chronic disease management. Through its subsidiary Parallax Development Corp, the company developed the REVOLUTION platform, a telehealth solution designed to integrate data from various medical devices to improve patient outcomes. The company also operated Parallax Diagnostics, which aimed to provide point-of-care testing solutions using its patented F.A.S.T. technology. However, the company's operations effectively ceased following SEC enforcement actions in 2020 related to misleading claims about its capabilities regarding COVID-19 testing and equipment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parallax Developments.